Cargando…
Clinical Presentation and Prognostic Features in Patients with Immunotherapy-Induced Vitiligo-like Depigmentation: A Monocentric Prospective Observational Study
SIMPLE SUMMARY: In this study, we thoroughly explore the clinical and biological features of immunotherapy-induced vitiligo-like depigmentation (VLD) in patients with stage III-IV melanoma receiving immunotherapy. Key findings include a distinct immune signature with an upregulation of ITGA in the V...
Autores principales: | Hermann, Nicola, Maul, Lara Valeska, Ameri, Milad, Traidl, Stephan, Ziadlou, Reihane, Papageorgiou, Karolina, Kolm, Isabel, Levesque, Mitchell, Maul, Julia-Tatjana, Brüggen, Marie-Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558529/ https://www.ncbi.nlm.nih.gov/pubmed/36230498 http://dx.doi.org/10.3390/cancers14194576 |
Ejemplares similares
-
Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011) -
The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis
por: Guillet, Carole, et al.
Publicado: (2022) -
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
por: Agarwal, Priti, et al.
Publicado: (2014) -
CCL22 to activate Treg migration and suppress depigmentation in vitiligo
por: Eby, Jonathan M., et al.
Publicado: (2015) -
Psychosocial and quality-of-life factors associated with depigmentation therapy for vitiligo
por: Cadmus, Simi D., et al.
Publicado: (2023)